Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
AstraZeneca and Targacept announce first top-line Phase III results for TC-5214 as an adjunct treatment in patients with major depressive disorder
-
AstraZeneca PLC Third quarter and nine months results 2011
-
US Food and Drug Administration extends action date for dapagliflozin by three months
-
AstraZeneca to present new healthcare economics data demonstrating cost-effectiveness of BRILIQUE at ISPOR EU
-
AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam to treat serious Gram-negative bacterial infections
-
AstraZeneca increases investment in China with new $200 million manufacturing facility
-
AstraZeneca enters into a settlement agreement with Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd regarding US SEROQUEL XR® patent litigation
-
BRILIQUE receives a positive preliminary medical benefit assessment for the majority of ACS patients in Germany as part of new AMNOG review process
-
AstraZeneca enters into a settlement agreement with Handa Pharmaceuticals regarding US SEROQUEL XR® patent litigation
-
AstraZeneca announces first approval of FASLODEX™ (fulvestrant) in Japan
Latest articles and press releases
All of our latest press releases and articles are available to explore
